Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for Myocardial Fibrosis in Elderly Heart Failure Patients
ChiCTR2600127726Phase 4Recruiting
- Sponsor
- The Eighth People's Hospital of Hebei Province
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of empagliflozin in heart failure (HF) (2 arms), sponsored by The Eighth People's Hospital of Hebei Province. Primary endpoints: Matrix Metalloproteinase-9, Left Ventricular Ejection Fraction and 1 more. Started Jul 2026; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2600127726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127726.